About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Phoenix | 99 Studies

Clinical Trials EpilepsyPhoenix

Epilepsy Clinical Trials in Phoenix

Find 99 clinical trials for epilepsy near Phoenix, Arizona. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 99 trials

CompletedStudy Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresThis study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of Primary Generalized Tonic-Clonic…NCT00104416·Anniston, Alabama and 145 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial SeizuresTo evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.NCT00141388·Birmingham, Alabama and 55 others

CompletedStudy to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresThe purpose of this study is to allow eligible subjects from the parent study, SP925 \[NCT00655551\] to continue lacosamide and to obtain additional long-term safety dataNCT00655486·Phoenix, Arizona and 6 others

CompletedBrivaracetam Safety and Efficacy Follow-up Study in Subjects With EpilepsyThis is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).NCT01339559·Phoenix, Arizona and 183 others

Enrolling by invitationElectrochemical and Electrophysiological StudyThis study will utilize computerized algorithms in combination with real-time intracranial neurophysiological and neurochemical recordings and microstimulation to measure…NCT05273970·Phoenix, Arizona

RecruitingEpilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)Concurrent electroencephalography (EEG) and new tripolar EEG (tEEG) will be recorded from adult and pediatric patients.NCT05944692·Phoenix, Arizona and 1 other

CompletedRNS® System Feasibility StudyThe RNS® System is intended to treat patients with medically refractory (hard to treat) epilepsy.NCT00079781·Phoenix, Arizona and 11 others

CompletedA Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure EpisodeThe purpose of this study is to determine the pharmacokinetics of Diazepam Nasal Spray following a single dose in epileptic patients experiencing a seizure episode.NCT01417078·Phoenix, Arizona and 3 others

CompletedChildhood Absence Epilepsy Rx PK-PD-Pharmacogenetics StudyThe purpose of this study is to determine the best initial treatment for childhood absence epilepsy.NCT00088452·Birmingham, Alabama and 30 others

Enrolling by invitationAn Open-label Study of XEN1101 in EpilepsyThis study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FOS) or Primary Generalized…NCT05718817·Phoenix, Arizona and 151 others

CompletedConversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial EpilepsyThis study is being conducted to determine the effectiveness of a lower monotherapy dose of lamotrigine than that currently approved.NCT00355082·Alabaster, Alabama and 102 others

CompletedEvaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial SeizuresEvaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizuresNCT00772603·Huntsville, Alabama and 70 others

CompletedStudy to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With EpilepsyThis study is conducted to assess the retention rate of Fycompa when given in routine clinical care.NCT03208660·Phoenix, Arizona and 43 others

Active not recruitingOpen-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset EpilepsyCenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal)…NCT06453213·Phoenix, Arizona and 18 others

CompletedHeart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With EpilepsyCharacterization of the cardiac response (ECG) preceding an epileptic seizure.NCT01214707·Phoenix, Arizona and 1 other

CompletedDose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset SeizuresThe primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures following single and…NCT04903314·Phoenix, Arizona and 12 others

CompletedA 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresA 12-week Evaluation Period will be used to characterize potential cognitive and neuropsychological effects of LEV (20 - 60 mg/kg/day), as adjunctive treatment in children 4 - 16…NCT00105040·Birmingham, Alabama and 44 others

CompletedPhase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal EpilepsyThe primary efficacy objective of the study is to determine if adjunctive therapy of natalizumab 300 mg intravenous (IV) every 4 weeks reduces the frequency of seizures in adult…NCT03283371·Birmingham, Alabama and 30 others

CompletedLamotrigine Extended-Release In Elderly Patients With EpilepsyThis study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy.NCT00516139·Birmingham, Alabama and 62 others

Completed4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial SeizuresThe purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures.NCT00368472·Birmingham, Alabama and 46 others

Page 1 of 5Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia